Assessment of 21-[18F]fluoro-16 alpha-ethyl-19-norprogesterone as a positron-emitting radiopharmaceutical for the detection of progestin receptors in human breast carcinomas.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Journal of Nuclear Medicine

• Publication date

  1991-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 1869974
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumor nuclear grade, estrogen receptor, and progesterone receptor: Their value alone or in combination as indicators of outcome following adjuvant therapy for breast cancer

  2005cited by this paper
• Positron tomographic assessment of 16 alpha-[18F] fluoro-17 beta-estradiol uptake in metastatic breast carcinoma.

  1991cited by this paper
• Breast cancer: PET imaging of estrogen receptors.

  1988cited by this paper
• Induction of progesterone receptor with tamoxifen in human breast cancer with special reference to its behavior over time

  1988cited by this paper
• 21-[18F]fluoro-16 alpha-ethyl-19-norprogesterone: synthesis and target tissue selective uptake of a progestin receptor based radiotracer for positron emission tomography.

  1988cited by this paper
• Breast cancers negative for estrogen receptor but positive for progesterone receptor, a true entity?

  1987cited by this paper
• Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer.

  1987cited by this paper
• Endocrine therapy for advanced carcinoma of the breast: relationship between the effect of tamoxifen upon concentrations of progesterone receptor and subsequent response to treatment.

  1987cited by this paper
• Application of robotics to radiopharmaceutical preparation: controlled synthesis of fluorine-18 16 alpha-fluoroestradiol-17 beta.

  1986cited by this paper
• Preparation of four fluorine- 18-labeled estrogens and their selective uptakes in target tissues of immature rats.

  1984cited by this paper
• Estrogen receptor binding radiopharmaceuticals: II. Tissue distribution of 17 alpha-methylestradiol in normal and tumor-bearing rats.

  1983cited by this paper
• Steroid hormone receptors in human breast cancer.

  1983cited by this paper
• Influence of tumor estrogen and progesterone receptor levels on the response to tamoxifen and chemotherapy in primary breast cancer.

  1983cited by this paper
• 16 alpha-[77Br]bromoestradiol: dosimetry and preliminary clinical studies.

  1982cited by this paper
• Methodology for the synthesis and specific activity determination of 16 alpha-[77Br]-bromoestradiol-17 beta and 16 alpha-[77Br]-11 beta-methoxyestradiol-17 beta, two estrogen receptor-binding radiopharmaceuticals.

  1982cited by this paper
• 16 alpha-[77Br]bromo-11 beta-methoxyestradiol-17 beta: a gamma-emitting estrogen imaging agent with high uptake and retention by target organs.

  1982cited by this paper
• Radiotracers binding to estrogen receptors: I: Tissue distribution of 17 alpha-ethynylestradiol and moxestrol in normal and tumor-bearing rats.

  1982cited by this paper
• 16 alpha-[77Br]bromoestradiol-17 beta: a high specific-activity, gamma-emitting tracer with uptake in rat uterus and uterus and induced mammary tumors.

  1981cited by this paper
• Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor.

  1978cited by this paper
• Progesterone-binding proteins: in vitro binding and biological activity of different steroidal ligands.

  1975cited by this paper
• Photoaffinity labels for estrogen binding proteins of rat uterus.

  1973cited by this paper

• Molecular Imaging of Steroid Receptors in Breast Cancer.

  2024cites this paper
• Estrogen Receptor-Targeted and Progesterone Receptor-Targeted PET for Patients with Breast Cancer.

  2023cites this paper
• Non-conventional and Investigational PET Radiotracers for Breast Cancer: A Systematic Review

  2022influential citation
• Use of Radionuclide-Based Imaging Methods in Breast Cancer.

  2022cites this paper
• Radionuclide-Based Imaging of Breast Cancer: State of the Art

  2021cites this paper
• PET and SPECT Imaging of Steroid Hormone Receptors in the Brain

  2020cites this paper
• PET Imaging Agents (FES, FFNP, and FDHT) for Estrogen, Androgen, and Progesterone Receptors to Improve Management of Breast and Prostate Cancers by Functional Imaging

  2020influential citation
• Sex steroid hormones and brain function : PET imaging as a tool for research

  2019cites this paper
• Radioiodinated progesterone derivative for progesterone receptor targeting with enhanced nucleus uptake via phenylboronic acid conjugation.

  2019cites this paper
• 18F-labeled ethisterone derivative for progesterone receptor targeted PET imaging of breast cancer.

  2019cites this paper
• 3 Scintimammography-Molecular Imaging : Value and New Perspectives with 99 m Tc ( V )-DMSA

  2018cites this paper
• Dedicated breast gamma camera imaging and breast positron emission tomography (breast PET): Current status and future directions

  2018cites this paper
• Clinical Potential of Estrogen and Progesterone Receptor Imaging.

  2018cites this paper
• Sex steroid hormones and brain function: PET imaging as a tool for research

  2018cites this paper
• Dedicated Breast Gamma Camera Imaging and Breast PET: Current Status and Future Directions.

  2018cites this paper
• Synthesis and preliminary evaluation of a 18F‐labeled ethisterone derivative [18F]EAEF for progesterone receptor targeting

  2017cites this paper
• University of Groningen PET imaging of brain sex steroid hormone receptors and the role of estrogen in depression

  2017cites this paper
• Small Molecules for Active Targeting in Cancer

  2016cites this paper
• Gynäkologische und Brusttumoren

  2016cites this paper
• Development of digital silicon photomultipliers based detectors for high-resolution positron emission tomography

  2016cites this paper
• Imaging Diagnostic and Therapeutic Targets: Steroid Receptors in Breast Cancer

  2016cites this paper
• Current Status of Dedicated Breast PET Imaging

  2016cites this paper
• Molecular imaging using PET and SPECT for identification of breast cancer subtypes

  2016cites this paper
• Targeting lysyl oxidase for molecular imaging in breast cancer

  2015cites this paper
• Molecular imaging of targeted therapies with positron emission tomography: the visualization of personalized cancer care

  2015cites this paper
• Bench to bedside molecular functional imaging in translational cancer medicine: to image or to imagine?

  2015cites this paper
• University of Groningen PET imaging of brain sex steroid hormone receptors and the role of estrogen in depression Khayum,

  2015cites this paper
• Molecular imaging using PET for breast cancer

  2015cites this paper
• PET imaging of brain sex steroid hormone receptors and the role of estrogen in depression

  2015cites this paper
• Automated synthesis and dosimetry of 6-deoxy-6-[(18)F]fluoro-D-fructose (6-[(18)F]FDF): a radiotracer for imaging of GLUT5 in breast cancer.

  2014cites this paper
• PET and SPECT Imaging of Steroid Hormone Receptors

  2014cites this paper
• Progesterone receptor targeting with radiolabelled steroids: an approach in predicting breast cancer response to therapy.

  2013cites this paper
• Tumor-receptor imaging in breast cancer: a tool for patient selection and response monitoring.

  2013cites this paper
• Molecular Imaging Probes for Diagnosis and Therapy Evaluation of Breast Cancer

  2013cites this paper
• Scintimammography - Molecular Imaging: Value and New Perspectives with 99mTc(V)-DMSA

  2012cites this paper
• Applications of Positron Emission Tomography in the Development of Molecular Targeted Cancer Therapeutics

  2012cites this paper
• Steroid receptor ligands for breast cancer targeting: an insight into their potential role as PET imaging agents

  2012cites this paper
• A steroid-conjugated magnetic resonance probe enhances contrast in progesterone receptor expressing organs and tumors in vivo.

  2011cites this paper
• acid, [ 18 F]DCFPyL, a PSMA-based PET Imaging Agent for Prostate Cancer

  2011cites this paper
• 2-(3-{1-Carboxy-5-[(6-[18F]Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid, [18F]DCFPyL, a PSMA-Based PET Imaging Agent for Prostate Cancer

  2011cites this paper
• Imaging cellular receptors in breast cancers: an overview.

  2011cites this paper
• Development of [F-18]fluorine-substituted Tanaproget as a progesterone receptor imaging agent for positron emission tomography.

  2010cites this paper
• Receptor Imaging in Patients with Breast Cancer.

  2009cites this paper
• Molecular imaging as a tool for translating breast cancer science

  2008cites this paper
• Tumor Receptor Imaging

  2008cites this paper
• PET imaging of steroid receptor expression in breast and prostate cancer.

  2008cites this paper
• Individualized treatment planning in oncology: role of PET and radiolabelled anticancer drugs in predicting tumour resistance.

  2008cites this paper
• Small molecule receptors as imaging targets.

  2008cites this paper
• Evaluation of a bromine-76-labeled progestin 16alpha,17alpha-dioxolane for breast tumor imaging and radiotherapy: in vivo biodistribution and metabolic stability studies.

  2008cites this paper
• Nuclear imaging of hormonal receptor status in breast cancer: a tool for guiding endocrine treatment and drug development.

  2007cites this paper
• Steroid Receptor Imaging in Breast Cancer.

  2006cites this paper
• Positron Emission Tomography

  2006cites this paper
• PET Imaging of Response and Resistance to Cancer Therapy

  2006cites this paper
• Positron tomographic assessment of androgen receptors in prostatic carcinoma

  2005cites this paper
• Current Imaging Paradigms in Radiation Oncology

  2005cites this paper
• Fluorinated tracers for imaging cancer with positron emission tomography

  2004cites this paper
• Synthesis of the 7α-cyano-(17α,20E/Z)-[125I]iodovinyl-19-nortestosterones: potential radioligands for androgen and progesterone receptors

  2003cites this paper
• Positron emission tomography (PET): Expanding the horizons of oncology drug development

  2003cites this paper
• Assessment of Cancer-Associated Biomarkers by Positron Emission Tomography: Advances and Challenges

  2003cites this paper
• Synthesis of the 7alpha-cyano-(17alpha,20E/Z)-[125I]iodovinyl-19-nortestosterones: potential radioligands for androgen and progesterone receptors.

  2003cites this paper
• An efficient route for the preparation of a 21-fluoro progestin-16 alpha,17 alpha-dioxolane, a high-affinity ligand for PET imaging of the progesterone receptor.

  2002cites this paper
• Nuclear medicine in primary breast cancer imaging.

  2002cites this paper
• Positron-emission tomographic imaging of cancer: glucose metabolism and beyond.

  2001cites this paper
• Steroids Labeled with 18F for Imaging Tumors by Positron Emission Tomography

  2001cites this paper
• PET imaging in breast cancer.

  2001cites this paper
• Imaging of Anticancer Drugs for Therapeutic Response and Prognosis

  2001cites this paper
• The Potential Role of Positron Emission Tomography in Investigation of Microenvironment

  2000cites this paper
• Characterizing tumors using metabolic imaging: PET imaging of cellular proliferation and steroid receptors.

  2000cites this paper
• Current developments of 18F-labeled PET tracers in oncology

  2000cites this paper
• Current Tumor Imaging Agents

  1999cites this paper
• The role of 99mTc-sestamibi and other conventional radiopharmaceuticals in breast cancer diagnosis.

  1999cites this paper
• Risques héréditaires de cancers du sein et de l'ovaire : quelle prise en charge ?

  1998cites this paper
• PET imaging of breast cancer with fluorine-18 radiolabeled estrogens and progestins.

  1998cites this paper
• PET radiopharmaceuticals: state-of-the-art and future prospects.

  1998cites this paper
• New iodinated progestins as potential ligands for progesterone receptor imaging in breast cancer. Part 1: Synthesis and in vitro pharmacological characterization.

  1998cites this paper
• PET in breast cancer.

  1998cites this paper
• New Approaches for Positron Emission Tomography ( PET ) in Breast Carcinoma

  1998cites this paper
• Estrogen and Progestin Radiopharmaceuticals for Imaging Breast Cancer

  1997cites this paper
• Syntheses of [21-11C] and (21-13C)progesterone

  1997cites this paper
• Scintigraphic imaging of breast tumors.

  1997cites this paper
• Nuclear medicine techniques for the study of breast cancer

  1997cites this paper
• The development of estrogen and progestin radiopharmaceuticals for imaging breast cancer.

  1997cites this paper
• Steroid Hormone Receptors as Targets for Diagnostic Imaging

  1996cites this paper
• Positron Emission Tomography using [18F]fluorotamoxifen to Evaluate Therapeutic Responses in Patients with Breast Cancer: Preliminary Study

  1996cites this paper
• Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose

  1996cites this paper
• Tumor receptor imaging: proceedings of the National Cancer Institute workshop, review of current work, and prospective for further investigations.

  1995cites this paper
• 6α-[18F]Fluoroprogesterone: Synthesis via halofluorination-oxidation, receptor binding and tissue distribution

  1995cites this paper
• 6 alpha-[18F]fluoroprogesterone: synthesis via halofluorination-oxidation, receptor binding and tissue distribution.

  1995cites this paper
• Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement.

  1995cites this paper
• Synthesis of 11 beta-[18F]fluoro-5 alpha-dihydrotestosterone and 11 beta-[18F]fluoro-19-nor-5 alpha-dihydrotestosterone: preparation via halofluorination-reduction, receptor binding, and tissue distribution.

  1995cites this paper
• The application of receptor theory to receptor-binding and enzyme-binding oncologic radiopharmaceuticals.

  1994cites this paper
• Synthesis of 6α-[18F]Fluoroprogesterone: A first step towards a potential receptor-ligand for PET

  1994cites this paper
• Synthesis of (17α, 20E/Z)Iodovinyl testosterone and 19-nortestosterone derivatives as potential radioligands for androgen and progesterone receptors

  1994cites this paper
• Metabolism of a [18F]fluorine labeled progestin (21-[18F]fluoro-16 alpha-ethyl-19-norprogesterone) in humans: a clue for future investigations.

  1994cites this paper
• Positron emission tomography and breast masses: Comparison with clinical, mammographic, and pathological findings

  1994cites this paper
• Synthesis of 6 alpha-[18F]fluoroprogesterone: a first step towards a potential receptor-ligand for PET.

  1994cites this paper
• Feasibility study for positron emission mammography.

  1994cites this paper
• Synthesis of (17 alpha,20E/Z)iodovinyl testosterone and 19-nortestosterone derivatives as potential radioligands for androgen and progesterone receptors.

  1994cites this paper